SCHEMBL6440895

SCHEMBL6440895

CCCCNC([NH])=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10455578 0.92
SCHEMBL5842289 0.90 EPHX1 (0.56)
SCHEMBL4755259 0.82
SCHEMBL1276675 0.80 EPHX1 (0.48)
SCHEMBL4075630 0.78
SCHEMBL1625755 0.76 EPHX1 (0.44)
SCHEMBL10981737 0.76
SCHEMBL19680558 0.76 EPHX1 (0.56)
SCHEMBL10846291 0.76
SCHEMBL42512 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936622-B2 6-phenylbenzonaphthyridines ALTANA PHARMA AG (DE) 2005-08-30 US claimed
EP-1377574-B1 6-PHENYLBENZONAPHTHYRIDINES BYK GULDEN LOMBERG CHEM FAB (DE) 2005-01-19 EP claimed
US-20040097537-A1 6-phenylbenzonaphthyridines TAKEDA GMBH (DE) 2004-05-20 US claimed
EP-1377574-B1 6-PHENYLBENZONAPHTHYRIDINES BYK GULDEN LOMBERG CHEM FAB (DE) 2005-01-19 EP disclosed
EP-0228192-A2 Renin-inhibitory oligopeptides, their preparation and use SANKYO COMPANY LIMITED (JP) 1987-07-08 EP disclosed